Rituximab Maintenance for Patients with Diffuse Large B-cell Lymphoma in First Complete Remission: Long-term Results of the HOVON-84 Randomized Phase III Study by the HOVON and the Nordic Lymphoma Group (clinical Trial Number: NTR1014)